Trial Outcomes & Findings for TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study (NCT NCT01198470)
NCT ID: NCT01198470
Last Updated: 2018-10-02
Results Overview
The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
COMPLETED
NA
20 participants
24 months
2018-10-02
Participant Flow
Participant milestones
| Measure |
TRIUMPH® Artificial Disc
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
18
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
TRIUMPH® Artificial Disc
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Overall Study
Adverse Event
|
2
|
Baseline Characteristics
TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
Baseline characteristics by cohort
| Measure |
TRIUMPH® Artificial Disc
n=20 Participants
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Age, Continuous
|
37.9 years
STANDARD_DEVIATION 9.8 • n=99 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=99 Participants
|
|
Height
|
67.2 inches
STANDARD_DEVIATION 3.0 • n=99 Participants
|
|
Weight
|
178.1 pounds
STANDARD_DEVIATION 26.1 • n=99 Participants
|
PRIMARY outcome
Timeframe: 24 monthsThe Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Outcome measures
| Measure |
TRIUMPH® Artificial Disc
n=18 Participants
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline
|
16 Participants
|
PRIMARY outcome
Timeframe: 24 monthsAny device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure
Outcome measures
| Measure |
TRIUMPH® Artificial Disc
n=20 Participants
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Number of Participants With No Device Failures
|
17 Participants
|
PRIMARY outcome
Timeframe: 24 monthsMajor vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.
Outcome measures
| Measure |
TRIUMPH® Artificial Disc
n=18 Participants
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage
|
0 Participants
|
PRIMARY outcome
Timeframe: 24 monthsNeurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows: Motor 0 Total Paralysis 1. Palpable or Visible Contraction 2. Active Movement, Gravity Eliminated 3. Active Movement, Against Gravity 4. Active Movement, Against Some Resistance 5. Active Movement, Against Full Resistance Sensory 0 Absent 1. Impaired 2. Normal Reflexes 0 Absent or Trace 1. Hyper-reflexive 2. Normal or hypo-reflexive Straight Leg Raise 0 0° - 70° (Abnormal) 1 \> 70°-90° (Normal) If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.
Outcome measures
| Measure |
TRIUMPH® Artificial Disc
n=18 Participants
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Number of Participants Determined to Have a Normal Neurological Status
|
15 Participants
|
Adverse Events
TRIUMPH® Artificial Disc
Serious adverse events
| Measure |
TRIUMPH® Artificial Disc
n=20 participants at risk
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
Surgical and medical procedures
Surgery - Index Level
|
15.0%
3/20 • Number of events 3 • 24 months
|
|
Gastrointestinal disorders
Gastric bypass to convert Lap Band
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Headache and fatigue
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
Renal and urinary disorders
Intrauterine Growth Restriction
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Trauma
|
5.0%
1/20 • Number of events 2 • 24 months
|
|
General disorders
Device migration
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Dural tear
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Dysesthesia - lower extremities
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Other
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Pain - back
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Weakness in bilateral legs
|
5.0%
1/20 • Number of events 1 • 24 months
|
Other adverse events
| Measure |
TRIUMPH® Artificial Disc
n=20 participants at risk
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
TRIUMPH® Lumbar Artificial Disc: The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
|---|---|
|
General disorders
Trauma
|
30.0%
6/20 • Number of events 10 • 24 months
|
|
Cardiac disorders
Hypertension
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Dural tear
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Headache
|
20.0%
4/20 • Number of events 4 • 24 months
|
|
General disorders
Pain - back
|
20.0%
4/20 • Number of events 5 • 24 months
|
|
General disorders
Pain - back and hip
|
10.0%
2/20 • Number of events 2 • 24 months
|
|
General disorders
Pain - back and lower extremities
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Pain - hip
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Pain - lower extremities
|
15.0%
3/20 • Number of events 5 • 24 months
|
|
General disorders
Pain - lower extremities with dysesthesia
|
5.0%
1/20 • Number of events 2 • 24 months
|
|
General disorders
Pain - neck and/or upper extremities
|
15.0%
3/20 • Number of events 3 • 24 months
|
|
General disorders
Wound issue
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
Musculoskeletal and connective tissue disorders
Muscle spasms
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Seizure type incidents
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Other
|
30.0%
6/20 • Number of events 6 • 24 months
|
|
General disorders
Dysesthesia - lower extremities
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Paresthesia - lower extremities
|
10.0%
2/20 • Number of events 2 • 24 months
|
|
Renal and urinary disorders
Urogenital
|
5.0%
1/20 • Number of events 1 • 24 months
|
|
General disorders
Weakness
|
5.0%
1/20 • Number of events 1 • 24 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee To prevent premature disclosure of trade secrets or other confidential information, PI agrees not to present, publish, or disclose study results or information about the investigational device without the express written consent of the sponsor.
- Publication restrictions are in place
Restriction type: OTHER